Affinage

DMWD

Dystrophia myotonica WD repeat-containing protein · UniProt Q09019

Length
674 aa
Mass
70.4 kDa
Annotated
2026-04-28
21 papers in source corpus 7 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

DMWD is a WD repeat-containing protein enriched in brain and testis that functions as a direct activator of the USP12 and USP46 deubiquitinases, binding USP12 at the same interface as WDR20 in a mutually exclusive manner and differentially directing USP12 subcellular localization to potentially distinct substrate repertoires (PMID:33844468). In neurons, DMWD localizes to the cell body, nucleus, dendrites, and synapses but is excluded from axons, and its protein levels are post-transcriptionally regulated during brain development (PMID:12691844). Haploinsufficiency of Dmwd in a multigene heterozygous mouse model contributes to multisystemic phenotypes of myotonic dystrophy type 1 (DM1), and DMWD transcript levels from the disease allele are selectively reduced in the cytoplasm of DM1 patient cells (PMID:31853004, PMID:10400997).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 1992 Medium

    Identification of DMWD as a transcribed gene adjacent to DMPK established it as a candidate contributor to myotonic dystrophy pathogenesis, though its function was entirely unknown.

    Evidence cDNA characterization and Northern blotting showing brain- and testis-enriched expression

    PMID:1302022

    Open questions at the time
    • No protein function assigned
    • Expression data limited to Northern blot tissue survey
    • Relationship to DM1 phenotype unresolved
  2. 1995 Medium

    Recognition of two WD repeat domains in DMWD placed it in a protein family involved in signal transduction and regulatory scaffolding, providing the first structural clue to function.

    Evidence Genomic sequencing and RNA in situ hybridization in mouse testis

    PMID:7633444

    Open questions at the time
    • No binding partners or enzymatic activity identified
    • WD repeat domains are highly versatile — specific molecular role unknown
  3. 1999 Medium

    Demonstration of allele-specific cytoplasmic reduction of DMWD RNA in DM1 cells established that the expanded CTG repeat affects DMWD expression post-transcriptionally, providing a mechanism for potential haploinsufficiency.

    Evidence Quantitative allele-specific RT-PCR on nuclear versus cytoplasmic RNA fractions from DM1 patient fibroblasts

    PMID:10400997

    Open questions at the time
    • Mechanism of cytoplasmic RNA reduction (transport vs. degradation) not defined
    • Protein-level consequences not measured
    • Single cell-line study
  4. 2003 Medium

    Subcellular mapping of DMWD protein in neurons revealed somatodendritic and synaptic enrichment with axonal exclusion, and developmentally increasing protein despite stable mRNA, establishing post-transcriptional control and implicating DMWD in synaptic biology.

    Evidence Western blotting, immunohistochemistry, and immunofluorescence in developing mouse brain and cultured neurons

    PMID:12691844

    Open questions at the time
    • No functional assay at the synapse performed
    • Post-transcriptional regulatory mechanism (translation vs. stability) undefined
    • Axonal exclusion mechanism unknown
  5. 2019 Medium

    A multigene heterozygous mouse model demonstrated that Dmwd dosage reduction contributes to congenital DM1 manifestations beyond those caused by Dmpk, Six5, and Mbnl1 haploinsufficiency alone, establishing DMWD as a functional contributor to DM1 pathogenesis.

    Evidence Genetic epistasis using quadruple heterozygous mice generated via haploid ESC injection with systematic phenotypic analysis

    PMID:31853004

    Open questions at the time
    • Specific downstream pathways affected by Dmwd haploinsufficiency not identified
    • Single mouse model; contribution of individual organs not dissected
    • Whether DMWD reduction alone is sufficient for any DM1-like phenotype untested
  6. 2021 High

    Identification of DMWD as a direct binding partner and activator of USP12/USP46 deubiquitinases — competing with WDR20 for the same interface and redirecting USP12 localization — provided the first defined molecular function for DMWD.

    Evidence Co-immunoprecipitation of epitope-tagged proteins, deubiquitinase activity assays, and subcellular localization studies in cultured cells

    PMID:33844468

    Open questions at the time
    • Endogenous substrates of the DMWD–USP12 complex not identified
    • Whether mutually exclusive binding with WDR20 occurs in vivo under physiological conditions not confirmed
    • Structural basis of the shared binding interface not resolved at atomic level

Open questions

Synthesis pass · forward-looking unresolved questions
  • The endogenous substrates deubiquitinated by DMWD-directed USP12 complexes, and how loss of this activity mechanistically drives the neuronal and multisystemic phenotypes of DM1, remain unknown.
  • No USP12 substrates specific to DMWD-containing complexes identified
  • Synaptic function of DMWD not tested by loss-of-function in neurons
  • Relationship between deubiquitinase activation and DM1 phenotypes not established

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 1
Localization
GO:0005634 nucleus 1 GO:0005829 cytosol 1
Pathway
R-HSA-392499 Metabolism of proteins 1
Partners
USP12USP46

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1992 DMWD (DMR-N9) was identified as an active gene in close proximity to the DMPK gene, with transcripts mainly expressed in brain and testis, possessing a single large open reading frame encoding a protein of unknown function. cDNA characterization, Northern blotting Nature genetics Medium 1302022
1995 The DMWD protein (mouse DMR-N9) contains two WD repeat domains, placing it in a family of proteins engaged in signal transduction or cell regulatory functions. Expression is ubiquitous at low levels with enhanced expression in adult brain and testis, and in testis is restricted to secondary spermatocytes of stages VIII–XII of the spermatogenic cycle. Genomic sequencing, Northern blotting, RNA in situ hybridization Human molecular genetics Medium 7633444
1999 In DM1 patient cell lines, the level of DMWD RNA from the disease-associated allele is reduced by 20–50% in the cytoplasmic fraction compared to the wild-type allele, but no such reduction is observed in the nuclear fraction, indicating allele-specific post-transcriptional regulation of DMWD in DM1. Quantitative allele-specific RT-PCR on nuclear and cytoplasmic RNA fractions from DM cell lines Human molecular genetics Medium 10400997
2003 DMWD protein (doublet of ~70 kDa) is developmentally regulated in mouse brain: mRNA remains constant postnatally (P7–P21) while protein levels gradually increase, indicating post-transcriptional regulation. DMWD protein is distributed in a punctate fashion throughout the neural cell body, nucleus, and dendrites including synapses, but is excluded from axons, and is most prominent in synapse-dense brain areas. Western blotting, immunohistochemistry, immunofluorescence in developing mouse brain and neuronal cell cultures Brain research Medium 12691844
2021 DMWD directly binds both USP12 and USP46 deubiquitinases, sharing the same binding interface on USP12 as WDR20 (suggesting mutually exclusive binding). DMWD promotes USP12 enzymatic activity. DMWD and WDR20 differentially modulate the subcellular localization of USP12, potentially directing the deubiquitinase complex to different substrate repertoires. Co-immunoprecipitation of epitope-tagged proteins, in silico interactome analysis, deubiquitinase activity assay, subcellular localization studies The FEBS journal High 33844468
2019 Genetic epistasis in mice shows that heterozygous loss of Dmwd combined with heterozygous mutations in Dmpk, Six5, and Mbnl1 (quadruple heterozygous) recapitulates major manifestations of congenital DM1 beyond those seen in triple heterozygous (Dmpk/Six5/Mbnl1) mice, demonstrating that Dmwd dosage reduction contributes to DM1 multisystemic phenotypes. Genetic epistasis — multigene heterozygous mouse models generated via haploid ESC injection, phenotypic analysis Cell research Medium 31853004
2025 Experimental perturbation of DMWD (Drosophila ortholog) in fly AD models showed that reversing the aberrant downregulation of DMWD was neuroprotective, reducing neuronal dysfunction in tau and amyloid AD fly models. Drosophila loss-of-function/gain-of-function in AD models, behavioral assays American journal of human genetics Low 40215969

Source papers

Stage 0 corpus · 21 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1992 Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nature genetics 155 1302022
1999 Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Human molecular genetics 66 10400997
1993 Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 64 7905855
1998 Expanding complexity in myotonic dystrophy. BioEssays : news and reviews in molecular, cellular and developmental biology 61 9872056
1995 Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus. Human molecular genetics 52 7633444
2000 The Aspergillus nidulans creC gene involved in carbon catabolite repression encodes a WD40 repeat protein. Molecular & general genetics : MGG 39 10852476
2001 Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy. Molecular genetics and metabolism 33 11592825
2003 Transgenic mouse models for myotonic dystrophy type 1 (DM1). Cytogenetic and genome research 24 14526185
2016 Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood. Epigenomics 22 26756355
2019 Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1. Cell research 21 31853004
2003 The DMWD protein from the myotonic dystrophy (DM1) gene region is developmentally regulated and is present most prominently in synapse-dense brain areas. Brain research 17 12691844
2016 Methyl-Arginine Profile of Brain from Aged PINK1-KO+A53T-SNCA Mice Suggests Altered Mitochondrial Biogenesis. Parkinson's disease 13 27034888
2001 Decreased DMPK transcript levels in myotonic dystrophy 1 type IIA muscle fibers. Biochemical and biophysical research communications 13 11527424
2000 Independent regulation of the myotonic dystrophy 1 locus genes postnatally and during adult skeletal muscle regeneration. The Journal of biological chemistry 12 10748037
2003 Searching for candidate genes for male infertility. Asian journal of andrology 9 12778326
2025 Computational and functional prioritization identifies genes that rescue behavior and reduce tau protein in fly and human cell models of Alzheimer disease. American journal of human genetics 5 40215969
2021 The dystrophia myotonica WD repeat-containing protein DMWD and WDR20 differentially regulate USP12 deubiquitinase. The FEBS journal 3 33844468
2004 Real-time RT-PCR for CTG repeat-containing genes. Methods in molecular biology (Clifton, N.J.) 3 15201450
2026 Functional Analysis of Late-Onset Alzheimer's Disease Risk Genes in Caenorhabditis elegans Identifies Regulators of Neuronal Aging. bioRxiv : the preprint server for biology 0 41959118
2025 Rodent Breathing Waveforms in ApoE Rats: Statistical and Entropic Differentiation. ArXiv 0 40406078
2025 Identification of novel therapeutic targets for liver fibrosis, cirrhosis, and hepatocellular carcinoma via dual-omics analysis and preliminary exploration of regulatory mechanisms. Clinical and experimental hepatology 0 42021999